Real-world safety profile of sonidegib: a disproportionality analysis based on the FDA adverse event reporting system
This study analyzed the real-world safety of sonidegib and emphasized the importance of continuous monitoring during the early stages of treatment. These findings provide important safety information for clinicians, but further research is needed to validate these results.
Authors
- Shengxiang Xiao (ORCID: https://orcid.org/0000-0002-3863-1065)
- Jiashu Liu (ORCID: https://orcid.org/0000-0003-4545-616X)
- Jing Li (ORCID: https://orcid.org/0000-0002-7418-8101)
- Qing Li (ORCID: https://orcid.org/0000-0002-4982-1024)
- Miao Qin
- Kaidi Zhao (ORCID: https://orcid.org/0000-0001-6716-3179)
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xi’an Children’s Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-23
- DOI
- https://doi.org/10.3389/fonc.2025.1642867
- Primary Topic
- Oral and gingival health research
- Type
- article
- Field-Weighted Citation Impact
- 0.00